Request Your Free White Paper Now:

"Integrating Pharmacogenomics Into the Standard of Care"

This white paper from Thermo Fisher Scientific discusses hurdles to the wider adoption of PGx and how PGx can improve care and reduce wasted time and costs for the healthcare system, patients, insurers, and patients’ employers -- highlighting applications in oncology, pain management, and mental health.

Pharmacogenomics (PGx) is used to understand how variations in key areas of an individual’s DNA may impact the efficacy of a medication, dosage considerations, and adverse drug reactions (ADRs). Ideally, testing is performed in advance of prescribing medication so that the physician or the pharmacist can streamline medication selection, reduce trial-and-error, and minimize ADRs. Alternatively, it can help explain why a medication is not working or causing an ADR to get the individual back on the best therapeutic path.

This white paper from Thermo Fisher Scientific discusses hurdles to the wider adoption of PGx and how PGx can improve care and reduce wasted time and costs for the healthcare system, patients, insurers, and patients’ employers — highlighting applications in oncology, pain management, and mental health.

Offered Free by: Thermo Fisher Scientific
See All Resources from: Thermo Fisher Scientific